We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

The Preferred Option Sample Clauses

The Preferred Option. A SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis for each of the short listed options was carried out by the key stakeholders group. This was supported by site analysis from an architect showing primary views to the sites, information on climate and form, location factors around access and transport, site sketch showing the key building blocks in a possible in situ solution. Indicative Site Plan for New Build at Xxxxxxx Street. Overall, the non-financial option appraisal process identifies that the preferred non-financial option is Option 6e (New build at Xxxxxxx Street) with 879 points, followed by option 6d (New build at Xxxxx Xxxx) with 632 points. There is then a gap to the very similarly scoring options 4b (Refurbish Xxxxx Xxxx) with 435 points; 5c (New build on adjacent car park site) with 431 points and 5d (New build at Lochgelly North School) also with 431 points. Option 1 (The Status Quo) was placed last in this analysis with 256 points. There is thereafter very little to choose between the balance of options, none of which score terribly highly. It is important to note however that all options scored considerably higher than Option 1, ‘Do nothing’ in most variations, with only option 5d) ever scoring less and then only when considering clinical group scoring in isolation. In summary, it is possible to conclude that all of the stakeholder groups engaged in this process:  Are likely to support Option 6e) as an overall preferred option, unless something radical changes.  Do not support the ‘do nothing’ option in any way.  See little difference between the relative merits of options 5b), 5d) and 4b). In addition, the outturns appear to provide NHS Fife with both a clearly preferred direction of travel (new build in Lochgelly to deliver the developing service model) and site option (Xxxxxxx Street) along with a mandate to further explore/develop Option 6e) in the short term subject to the outcomes of formal financial option appraisal.
The Preferred Option. By comparing the pros and cons of the various construction methods, the preferred option is trench excavation by grab dredging by one grab dredger and install the submarine watermain by the “bottom-pull method” followed by protection of the submarine piepeline by backfilling with 4.5m thick armour rock layer with a 0.3m thick grade 75 bedding layer.
The Preferred OptionAs indicated before, Option 4B was proposed initially to be considered as preferred option. But, given the fact that the additional analysis of Option 5 has proven its economic viability and beneficial character for the LWSC this option was finally selected as the preferred option. Under Option 5, a wastewater treatment structure with two WWTPs – New Ngwerere and New Chunga WWTPs will be considered. Manchinchi WWTP including the Garden ponds are proposed to be decommissioned and sold. • Demolition of structures and buildings; • Transport and disposal of construction waste at Chunga landfill; and • Levelling of land. Sale of the excess areas is proposed after completion of the project and is expected to take place over a period from 2019 to 2025.
The Preferred OptionService Change Planning Strategic Assessment Initial Agreement Outline Business Case Final BusinessCase Implementation Phase The preferred service delivery option is to continue with the existing arrangement of NHS Lothian contracting with the East Calder Medical Practice to provide General Medical Services to the practice population under the terms of the 2018 GMS Contract. This will include provision of additional GP, Advanced Nurse Practitioner and Practice Nurse sessions. A range of community health services will continue to be provided from the facility including district nursing, health visiting, midwifery and community psychiatric nursing, physiotherapy, podiatry and speech and language therapy. In addition consultant psychiatry clinics and drug and alcohol counselling services will continue to be provided from visiting practitioners. The 2018 General Medical Services Contract in Scotland (GMS 2018) identified a number of priority areas for service redesign. Proposed changes to the workforce will be phased in line with population growth and service model developments and have taken into account the requirements for new roles such as advanced practitioners in physiotherapy, pharmacotherapy and nursing as part of the enhanced primary healthcare team as well as the need to transfer the vaccination programme to community services and to develop community treatment and care (CTAC) services.
The Preferred Option. A SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis for each of the Short Listed Options was carried out by the key stakeholder’s group. This was supported by site analysis from an architect showing primary views to the sites, information on climate and form, location factors around access and transport, site sketch showing the key building blocks in a possible in situ solution Overall, the non-financial option appraisal process identifies that the preferred non-financial option is option 6d (New build at Tulliallan Primary School) with 739 points, followed by option 6b) (New build at Feregait) with 539 points and option 6c) (New build at Station Road) with 509 points. Option 1 (The “Status Quo”) was placed last in this analysis with 221 points. All options scored considerably higher than Option 1, ‘Do nothing’. In summary, it is possible to conclude that all of the stakeholder groups engaged in this process:  Are likely to support Option 6d) as an overall preferred option, unless something radical changes  Do not support the ‘do nothing’ option in any way  See little difference between the relative merits of options 6b) and 6c). In addition, the outturns appear to provide NHS Fife with both a clearly preferred direction of travel in support of their developing Initial Agreement Document (new build in Kincardine to deliver the developing service model) and site option (Tulliallan Primary School) along with a mandate to further explore / develop Option 6d in the short term subject to the outcomes of formal financial option appraisal.
The Preferred Option. The preferred option to be taken forward to Full Business Case is Option 3: New Build on adjacent land, this considers Non-Financial and Financial benefits. This was identified as the preferred option because this is the only option which will accommodate anticipated population growth in the area and enable compliance with DDA requirements. A new build on the land to the rear of the existing building will enable provision to be maintained in an accessible central location, allow for expansion and optimisation of services, and support further integration of health and social care. In addition there would be no requirement to decant the existing facility which is key risk in Options 1 and 2. Consideration of major improvements under Option 2 to address maintenance and statutory standards will not facilitate significant improvements in space utilisation and service provision due to structural and layout constraints. The total Capital cost for Option 3 is £11.483m.

Related to The Preferred Option

  • Convertible Preferred Stock In accordance with the undersigned's obligation under the Subscription Agreement to provide such information as may be required by law for inclusion in the Registration Statement, the undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective. All notices hereunder and pursuant to the Subscription Agreement shall be made in writing at the address set forth below. In addition, the undersigned hereby agrees to give the Company three days' prior notice in advance of sales of Series A Convertible Preferred Stock pursuant to the Registration Statement, and the undersigned hereby further agrees not to sell Series A Convertible Preferred Stock in the event the undersigned knows of any undisclosed material developments or transactions relating to the Company. The undersigned hereby acknowledges that it understands that any sales or other dispositions of any Series A Convertible Preferred Stock pursuant to the Registration Statement, once effective, must be settled with Series A Convertible Preferred Stock bearing the Company's general (not necessarily restricted) common shares CUSIP number. A beneficial owner named in the Registration Statement may obtain Series A Convertible Preferred Stock bearing the Company's general common shares CUSIP number for settlement purposes by presenting the Series A Convertible Preferred Stock to be sold (with a restricted CUSIP), together with a certificate of registered sale, to the Company's transfer agent, North American Transfer Co. The form of certificate of registered sale is available from the Company upon request. The process of obtaining such shares might take a number of business days. SEC rules generally require trades in the secondary market to settle in three business days, unless the parties to any such trade expressly agree otherwise. Accordingly, a beneficial owner who holds Series A Convertible Preferred Stock with a restricted CUSIP at the time of the trade might wish to specify an alternate settlement cycle at the time of any such trade to provide sufficient time to obtain Series A Convertible Preferred Stock with an unrestricted CUSIP in order to prevent a failed settlement. By signing below, the undersigned consents to the disclosure of the information contained herein in its answers above and the inclusion of such information in the Registration Statement and the related prospectus. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus.

  • Series A Preferred Stock The Series A Preferred Stock shall have the following rights, preferences and limitations: i. The Series A Preferred Stock shall have a liquidation preference of $100 per share or an aggregate liquidation preference of $6.4 million. The liquidation preference shall be senior to all other securities of the Company including the Series B, C and D Preferred Stock described below and the Common Stock. ii. The Series A Preferred Stock shall not have specified dividends but shall be entitled to participate on an as-converted basis in any dividends paid on the Common Stock of the Company or the Series B, C or D Preferred Stock. iii. The Series A Preferred Stock shall not be subject to mandatory redemption at the election of the Investors but shall be subject to redemption at a redemption price of $100 per share by the Company at any time on or after ten (10) years after the original date of issuance. iv. The Series A Preferred Stock shall be convertible into shares of Common Stock at a conversion price of $1.00 per share. Each share of Series A Preferred Stock shall be initially convertible into 100 shares of Common Stock based on the $100 liquidation preferential amount thereof. The conversion price and number of shares will be subject to customary anti-dilution adjustments for stock splits, share dividends, recapitalizations, stock issuances, etc., with the anti-dilution adjustment for the issuance of shares at less than the conversion price being determined on the "weighted average method." v. Subject to the provisions of Section 3A hereof, the Series A Preferred Stock, voting as a single class, shall be entitled to elect a majority (4) of the Board of Directors. On all other matters, the holders of the Series A Preferred Stock shall vote together with the holders of the Common Stock and the Series B, C and D Preferred Stock and shall be entitled to cast one vote for each share of Common Stock into which the Series A Preferred Stock is convertible. vi. The approval of the Series A Preferred Stock, voting as a separate class, shall be required for the issuance of any securities having liquidation or other rights senior or superior or equal in any respect to the rights of the Series A Preferred Stock.

  • Treatment of Expired Options and Unexercised Convertible Securities If, in any case, the total number of shares of Common Stock issuable upon exercise of any Option or upon conversion or exchange of any Convertible Securities is not, in fact, issued and the rights to exercise such Option or to convert or exchange such Convertible Securities shall have expired or terminated, the Exercise Price then in effect will be readjusted to the Exercise Price which would have been in effect at the time of such expiration or termination had such Option or Convertible Securities, to the extent outstanding immediately prior to such expiration or termination (other than in respect of the actual number of shares of Common Stock issued upon exercise or conversion thereof), never been issued.

  • No Rights to Purchase Preferred Stock The issuance and sale of the Shares as contemplated hereby will not cause any holder of any shares of capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or other rights to purchase capital stock or any other securities of the Company to have any right to acquire any shares of preferred stock of the Company.

  • Vested Options On the next regularly scheduled payroll date of the Surviving Corporation occurring more than five (5) Business Days but less than twenty (20) Business Days following the Closing Date, the Surviving Corporation shall pay to each holder of a Vested Option (other than with respect to Non-Withholding Options) for whom Acquiror has received a duly executed Option Termination Agreement an amount in cash equal to the number of shares of Common Stock subject to such Vested Option multiplied by an amount equal to the difference between (a) the Per Share Closing Consideration, minus (b) the exercise price per share under such Vested Option, minus (c) such holder’s applicable Percentage of the Escrow Amount in respect of such Vested Option (the “Closing Options Payout Amount”). Following the Effective Time, the Paying Agent shall cause the applicable Closing Options Payout Amount to be paid to each holder of a Vested Option which is a Non-Withholding Option for whom Acquiror has received a duly executed Option Termination Agreement. The Closing Options Payout Amount payable to each holder of a Vested Option shall be set forth opposite such holder’s name on the Payment Schedule (such consideration subject to adjustment as provided herein and any applicable withholding Taxes). In the event of a conflict between the Payment Schedule and the provisions of this Agreement, the Payment Schedule shall control. Notwithstanding anything to the contrary herein or in the Company’s Amended and Restated Certificate of Incorporation (as amended as of the date hereof) (the “Restated Certificate”), Acquiror, Merger Sub, the Surviving Corporation, the Equityholder Representative and the Paying Agent shall be entitled to rely on the Payment Schedule as conclusive evidence of amounts payable to the holders of Vested Options pursuant to this Agreement. Each holder of a Vested Option, subject to receipt of a duly executed Option Termination Agreement, shall be entitled to receive with respect to each Vested Option subject thereto, such holder’s Percentage of the Earnout Payments, as and when such payments are required to be made, which amount shall be paid on the same schedule and on the same terms and conditions as apply to the Stockholders generally.

  • Series B Preferred Stock 1 Shares.......................................................................1

  • Company Preferred Stock “Company Preferred Stock” shall mean the Preferred Stock, $0.001 par value per share, of the Company.

  • GRANT OF THE RIGHT TO PURCHASE PREFERRED STOCK The Company hereby grants to the Warrantholder, and the Warrantholder is entitled, upon the terms and subject to the conditions hereinafter set forth, to subscribe for and purchase from the Company, 9,694 fully paid and non-assessable shares of the Company’s Series B Preferred Stock (“Preferred Stock”) at a purchase price of $4.90 per share (the “Exercise Price”). The number and purchase price of such shares are subject to adjustment as provided in Section 8 hereof.

  • Unvested Options Each unvested outstanding Company Option held by a Continuing Employee (each an “Unvested Company Option”) shall be assumed by Parent (the “Assumed Options”) and will continue to have, and be subject to, the same terms and conditions set forth in the applicable Unvested Company Option documents (including any applicable Company Option Plan and stock option agreement or other document evidencing such Unvested Company Option, including but not limited to any employment or other agreement providing for accelerated vesting or other terms governing such Assumed Options) immediately prior to the Effective Time (including any repurchase rights or vesting provisions), except that (i) each such Unvested Company Option will be exercisable (or will become exercisable in accordance with its terms) for that number of whole shares of Parent Stock equal to the product of the number of shares of Company Common Stock that were subject to such Unvested Company Option immediately prior to the Effective Time multiplied by the Conversion Rate (rounded down to the next whole number of shares of Parent Stock, with no cash being payable for any fractional share eliminated by such rounding), and (ii) the per share exercise price for the shares of Parent Stock issuable upon exercise of such assumed Unvested Company Option will be equal to the quotient determined by dividing the exercise price per share of Company Common Stock at which such Unvested Company Option was exercisable immediately prior to the Effective Time by the Conversion Rate, rounded up to the nearest whole cent. The assumption and conversion of Unvested Company Options by Parent are intended to satisfy the requirements of Treasury Regulations Section 1.424-1 (to the extent such options were incentive stock options) and of Treasury Regulations Section 1.409A-1(b)(5)(v)(D). Following the Effective Time, the Board of Directors of Parent or a committee thereof shall succeed to the authority and responsibility of the Board of Directors of Company or any committee thereof with respect to each Assumed Option and references to Company shall become references to Parent under the applicable Company Option Plan and stock option agreement or other document evidencing such Assumed Option. Each unvested outstanding Company Option that is not an Unvested Company Option shall be treated as a Cancelled Option and shall be cancelled and extinguished, with no consideration payable in connection with such cancellation and no further rights to the holder thereof, at the Effective Time.

  • Shares The term “